Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05910164Completed

Patient Preference Between a Prefilled Syringe or a Prefilled Pen Device for Administration of Pegfilgrastim

Role: lead

NCT06662864Completed

Study on Sleep, Lifestyle and Quality of Life in Women With Breast Cancer

Role: lead

NCT06317714Recruiting

Long-term Follow-up and Quality of Life of Patients Treated With Anticancer Drugs

Role: lead

NCT06428279Completed

Survey of Sexual Health in Cancer Patients

Role: lead

NCT05860660Completed

Screens, Virtual Reality and Digital Addiction (EVADD)

Role: lead

All 5 trials loaded